Source Nutraceutical, Inc.   Report issue

For profit
Founded: Winnipeg Canada (2004)
Status: No NME R&D (2004)

Organization Overview

First Clinical Trial
2019
NCT03910153
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Source Nutraceutical, Inc.

Active Ingredients

Drugs in Other Trials (2)

atropine (1 trial)

resistant starch (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2